Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.07 - $1.6 $18,320 - $27,395
17,122 New
17,122 $20,000
Q4 2022

Feb 14, 2023

BUY
$0.73 - $58.49 $5,315 - $425,924
7,282 Added 41.04%
25,024 $19,000
Q3 2022

Nov 14, 2022

BUY
$0.78 - $61.1 $13,838 - $1.08 Million
17,742 New
17,742 $14,000
Q2 2022

Aug 16, 2022

SELL
$0.78 - $1.1 $18,485 - $26,068
-23,699 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$0.82 - $1.1 $11,133 - $14,935
13,578 Added 134.16%
23,699 $21,000
Q4 2021

Feb 15, 2022

BUY
$0.96 - $1.63 $9,716 - $16,497
10,121 New
10,121 $11,000
Q2 2021

Aug 16, 2021

SELL
$1.56 - $2.13 $25,407 - $34,691
-16,287 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$1.65 - $3.87 $26,873 - $63,030
16,287 New
16,287 $31,000

About FSD Pharma Inc.


  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $146M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.